Improving predictions for transcatheter treatment of tricuspid valve issues

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This observational study aims to enhance the predictability of therapeutic success in transcatheter tricuspid valve interventions for patients suffering from severe tricuspid regurgitation. By utilizing automated analyses of pre-interventional computed tomography scans, the study seeks to identify factors that contribute to successful outcomes. Given the challenges associated with severe tricuspid regurgitation, including ineffective pharmacological therapy and high surgical mortality risks, this research focuses on catheter-based treatment strategies that have shown promise in reducing regurgitation severity. The ultimate goal is to improve patient quality of life through effective intervention.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* the patient underwent full cycle cardiac computed tomography for analysis of valvular heart disease
* a transcatheter tricuspid valve intervention is performed
* the patient is 18 years or older

Exclusion Criteria:

* none

Where it's running

• Herz- und Diabeteszentrum
  Bad Oeynhausen, North Rhine-Westphalia, Germany Recruiting

Study contacts

• Study coordinator: Johannes Kirchner, Dr. med.
• Email: jkirchner@hdz-nrw.de
• Phone: 0405731971258

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• 3D Echocardiography to See How CIEDs May Worsen Tricuspid Regurgitation

  This study tests whether different CIEDs (leadless pacemakers, LBBaP, and conventional pacemakers) differ in causing worsening tricuspid regurgitation, using 3D heart imaging.

  Recruiting Samsung Medical Center · Seoul, Seoul · NCT07793916

• Next-generation spectral CT imaging data collection from clinical scans

  This study tests how a new spectral CT system performs when used in real patient scans at St. Luke’s University Hospital Network to help with regulatory submissions.

  Recruiting GE Healthcare · Bethlehem, Pennsylvania · NCT07661706

• Compare leadless and left bundle branch pacemakers for heart and valve function

  This study tests whether leadless pacemakers or left bundle branch area pacing better preserve heart and tricuspid valve function in adults needing a pacemaker.

  Recruiting Guy's and St Thomas' NHS Foundation Trust · London · NCT07534917

• TriClip for treating tricuspid regurgitation in Japan

  This study will see if the TriClip device is safe and helps people in Japan with symptomatic severe tricuspid regurgitation when used in routine clinical care.

  Recruiting Abbott Medical Devices · Suita, Osaka · NCT07509658

• Impact of transcatheter tricuspid valve repair on kidneys, strength, and activity in older adults

  This study will try catheter-based tricuspid valve repair (TEER) in older adults with severe symptomatic tricuspid regurgitation to see if kidney function, fluid overload, and physical activity improve.

  Recruiting Robert Bosch Medical Center · Stuttgart · NCT07464106

• TARGET 2.0: Cardiovalve TR replacement for tricuspid regurgitation

  This study will test a percutaneously delivered Cardiovalve tricuspid replacement via the femoral vein in adults with symptomatic severe secondary tricuspid regurgitation who are high risk for open-heart surgery.

  Recruiting Cardiovalve Ltd. · Bonn · NCT07334691

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.